Webinars & Presentations Seminar: Dana Farber Cell Engineering-408-05172024

High Efficiency Cell Engineering Seminar - Hosted at Dana-Farber Cancer Institute

Join us at Dana-Farber Cancer Institute for an insightful seminar hosted by MaxCyte

Friday, May 17th, 2024
9:00 - 10:30 AM (EST)

In-Person Event
Dana Farber Cancer Institute
Smith 308/309
1 Jimmy Fund Way
Boston, MA 02115

About the seminar

Join us for an exciting cell engineering seminar on Friday, May 17^th from 9:00-10:30 am at Dana-Farber Cancer Institute Smith Research Laboratories!

Register to hear how guest speaker Vimal Keerthi from Stanford University's Cell Therapy Center leverages the MaxCyte platform to manufacture gene engineered products for patients. You will also gain valuable insights into how MaxCyte innovative electroporation platforms enable the efficient engineering of primary cells, stem cells, and many more cell lines.

Discover how our technology guarantees high cell viability and optimal recovery rates for a wide range of applications, including CRISPR, cell-based assays, cell therapy manufacturing, viral production, and so much more.

Breakfast will be on us: We value your time, and to keep the focus on learning, we're providing a complimentary breakfast for all in-person attendees.

RSVP by filling out this form to secure your seat!

Speakers

Vimal Keerthi

Process Development Scientist at Dr. Steven Feldman’s Lab, Stanford Laboratory of Cell and Gene Medicine Stanford Center for Cancer Cell Therapy

Vimal is a Process Development Scientist in Dr. Steven Feldman’s group at the Stanford Center for Cancer Cell Therapy focusing on developing CRISPR knock-in platforms for non-viral CAR-T manufacturing. Prior to working on non-viral platforms, Vimal worked on the process development of Allogeneic Hematopoietic Stem Cell Transplants and donor derived T-allo10 Tr1 cell therapies at Stanford’s cGMP Laboratory of Cell & Gene Medicine.

Leif Anderson, PhD

Field Application Scientist
MaxCyte, Inc.

Leif Anderson is a Senior Field Application Scientist at MaxCyte. Leif is a trained biomedical engineer with years of experience working with primary cells, including iPSC’s at the Salk Institute and hematopoietic stem cells at UC Davis. Leif’s professional experience prior to joining MaxCyte includes supporting product development and commercialization of gene therapy products at LUMICKS, Nanoview Biosciences, and Unchained Labs.

Emily Cox

Business Development Manager
MaxCyte, Inc.

Emily Cox is the Business Development Manager at Maxcyte dedicated to the New England region and New York. She holds a Bachelor's degree in Biology from Worcester State and a Master of Business from Southern New Hampshire University. With an extensive background spanning 9 years in the cell and gene therapy, as well as biologics space, Emily has honed her skills through roles at Unchained Labs, Opentrons Labworks, and Harvard Bioscience. Situated just outside of Boston, Emily collaborates with Leif to provide exceptional support to customers in the Boston area, as well as Connecticut, Rhode Island, and New York.

Register today

Registration for this seminar has now closed.